University of Aberdeen and Scotia Biologics Limited
Lead Participant:
UNIVERSITY OF ABERDEEN
Abstract
To develop, optimise, scale-up and commercialise two novel antibodies for use as flow cytometry reagents, improving the current method for the analysis of cell death. This will lead to advances in the diagnosis and treatment of various diseases including inflammatory diseases and cancer.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| UNIVERSITY OF ABERDEEN | £261,477 | £ 175,190 |
Participant |
||
| SCOTIA BIOLOGICS LIMITED |
People |
ORCID iD |